Cytokines, viruses, and graft-versus-host disease

Current Opinion in Hematology

Volumn 9, Issue 6, 2002, Pages 479-484

  Holler, Ernst ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS LIGAND; FLT3 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; AUTACOID;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CYTOKINE RELEASE; DNA POLYMORPHISM; GRAFT VERSUS HOST REACTION; HUMAN; MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TH1 CELL; VIRUS; ALLOTRANSPLANTATION; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE SYSTEM; IMMUNOLOGY; MICROBIOLOGY; VIRUS INFECTION;

CYTOKINES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; INFLAMMATION MEDIATORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS DISEASES;

EID: 0036838788     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200211000-00002     Document Type: Review

References (59)

1. Ferrara JLM, Antin JH: The pathophysiology of graft-versus-host disease. In: Hematopoietic cell transplantation. ED Thomas, KG Blume, SJ Forman eds. Blackwell Science Inc, Malden, USA 1999:305-315.
2. Goker H, Haznedaroglu IC, Chao NJ: Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001, 29:259-77.
3. Min CK, Lee WY, Min DJ, et al.: The kinetics of circulating cytokines including IL-6, TNF-α, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 28:935-40.
4. Sakata N, Yasui M, Okamura T, et al.: Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant 2001, 27:1153-61.
5. Teshima T, Ordemann R, Reddy P, et al.: Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002, 8:1-7.
6. Kobbe G, Schneider P, Rohr U, et al.: Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse anti-TNF-α antibody. Bone Marrow Transplant 2001, 28:47-9.
7. Brown GR, Lee E, Thiele DL: TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J->C57BL/6J × bm12) F1 mice. J Immunol 2002, 168:3065-71.
8. Hill GR, Teshima T, Gerbitz A, et al.: Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft-versus-leukemia. J Clin Invest 1999, 104:459-467.
9. Via CS, Shustov A, Rus V, et al.: In vivo neutralization of TNF-α promotes humoral autoimmunity by preventing the induction of CTL. J Immunol 2001, 167:6821-6.
10. Tamada K, Tamura H, Flies D, et al.: Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J Clin Invest 2002, 109:549-57.
11. Fujimori Y, Takatsuka H, Takemoto Y, et al.: Elevated interleukin 18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2000, 109:652-657.
12. Itoi H, Fujimori Y, Tsutsui H, et al.: Fas ligand-induced caspase-1 dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 2001, 98:235-7.
13. Reddy P, Teshima T, Kukuruga M, et al.: Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 2001, 194:1433-1440.
14. Kuroiwa T, Kakishita E, Hamano T, et al.: Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest 2001, 107:1365-1373.
15. Okamoto T, Takatsuka H, Fujimori Y, et al.: Increased hepatocyte growth factor in serum in acute graft-versus-host disease. Bone Marrow Transplant 2001, 28:197-200.
16. Kataoka Y, Iwasaki T, Kuroiwa T, et al.: The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease. Immunology 2001, 103:310-318.
17. Yang YG, Wang M-Q, Sykes M: Donor derived interferon-γ separates graft-vs-leukemia effects and graft-versus-host disease induced by donor CD8 cells. Blood 2002, 99:4207-4215.
18. Baker J, Verneris MR, Ito M, et al.: Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ. Blood 2001, 97:2923-2931.
19. Iijima H, Takahashi I, Kiyono H: Mucosal immune network in the gut for the control of infectious diseases. Rev Med Virol 2001, 11:117-133.
20. Liu J, Anderson BE, Robert ME, et al.: Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease. Blood 2001, 98:3367-3375.
21. Daneshpouy M, Socie G, Lemann M, et al.: Activated eosinophils in upper gastrointestinal tract of patients with graft versus host disease. Blood 2002, 99:3033-3040.
22. Alpdogan O, Schmaltz C, Muriglan SJ, et al.: Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001, 98:2256-2265.
23. Shlomchik WD, Couzens MS, Tang CB, et al.: Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415.
24. Ordemann R, Hutchinson R, Friedmann J, et al.: Enhanced allostimulatory activity of host antigen presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002, 109:1249-1256.
25. Teshima T, Ordemann R, Reddy P, et al.: Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002, 8:1-7.
26. Dickinson AM, Wang X-N, Sviland L, et al.: In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002, 8:410-414.
27. + cells with donor or host accessory cells induces acute graft-versus-host disease in human skin in immunodeficient mice. Exp Hematol 2001, 29:720-727.
28. Blazar BR, McKenna HJ, Panoskaltsis-Mortari A, et al.: Flt3 ligand (FL) treatment of murine donors does not modify GvHD but FL treatment of recipients post-bone marrow transplantation accelerates GvHD lethality. Biol Blood Marrow Transplant 2001, 7:197-207.
29. Teshima T, Reddy P, Lowler KP, et al.: Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 α (+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood 2002, 99:1825-1832.
30. Ruggeri L, Capanni M, Urbani E, et al.: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
31. Klangsinsirikul P, Carter GI, Byrne JL, et al.: Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood 2002, 99:2586-2591.
32. Korbling M, Anderlini P: Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001, 98:2900-2908.
33. Volpi I, Perruccio K, Tosti A, et al.: Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 2001, 97:2514-2521.
34. Paris F, Fuks Z, Kang A, et al.: Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001, 293:293-297.
35. Janin A, Deschaumes C, Daneshpouy M, et al.: CD95 engagement induces disseminated endothelial cell apoptosis in vivo: Immunopathologic implications. Blood 2002, 99:2940-2947.
36. Antin JH, Lee SJ, Neuberg D, et al.: A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. Bone Marrow Transplant 2002, 29:373-377.
37. Cavet J, Dickinson AM, Norden J, et al.: Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001, 98:1594-1600.
38. Socie G, Loiseau P, Tamouza R, et al.: Both genetic and clinical factors predict the development of graft-versus- host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001, 72:699-706.
39. Dickinson AM, Cavet J, Cullup H, et al.: GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro human skin explant model. Hum Immunol 2001, 62:1266-1276.
40. Ishikawa Y, Kashiwase K, Akaza T, et al.: Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 2002, 29:569-575.
41. Lorenz E, Schwarz DA, Martin PJ, et al.: Associations of TLR4 mutations and the risk of acute GvHD after HLA matched sibling hematopoietic cell transplantation. Biol Blood Marrow Transplant 2001, 7:384-387.
42. Yoshikawa T, Ihira M, Ohashi M, et al.: Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001, 28:77-81.
43. Zerr DM, Gooley TA, Yeoung L, et al.: Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001, 33:763-771.
44. Bordigoni P, Carret AS, Venard V, et al.: Treatment of Adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001, 32:1290-1297.
45. Runde V, Ross S, Trenschel R, et al.: Adenoviral infections after allogeneic stem cell transplantation (SCT): Report on 130 patients from a single SCT unit involved in a prospective multicenter trail. Bone Marrow Transplant 2001, 28:521-527.
46. Hofmann JA, Shah AJ, Ross LA, et al.: Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood & Marrow Transplant 2001, 7:388-394.
47. Lujan-Zilbermann J, Benaim E, Tong X, et al.: Respiratory virus infections in pediatric bone marrow transplantation. Clin Infect Dis 2001, 33:962-968.
48. Aubert G, Hassan-Walker AF, Madrigal JA, et al.: Cytomegalovirus specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 2001, 184:955-963.
49. Adler H, Beland JL, Kozlow W, et al.: A role for transforming growth factor-β 1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex type 1 infection. Blood 1998, 92:2581-2589.
50. Raftery MJ, Schwab M, Eibert SM, et al.: Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 2001, 15:997-1009.
51. Zak-Prelich M, Halliday KE, Walker C, et al.: Infection of murine keratinocytes with herpes simplex virus type 1 induces the expression of interleukin-10, but not interleukin-1 α or tumor necrosis factor-α. Immunology 2001, 104:468-475.
52. Chen Y, Rocha V, Bittencourt H, et al.: relation between HLA alleles and cytomegalovirus infection after allogeneic hematopoietic stem cell transplantar. Blood, 98:500-501.
53. Yamada S, Takatsuka H, Takemoto Y, et al.: Association of cytomegalovirus interstitial pneumonitis with HLA-type following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000, 25:861-865.
54. Nachbaur D, Bonatti H, Oberaigner W, et al.: Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors. Lancet 2001, 358:1157-1159.
55. Ziegler TR, Panoskaltsus-Mortari A, Gu LH, et al.: Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation. Transplantation 2001, 72:1354-1362.
56. Panoskaltsis-Mortari A, Hermanson JR, Haddad IY, et al.: Intercellular adhesion molecule-I (ICAM-I, CD54) deficiency segregates the unique pathophysiologic requirements for generating idiopathic pneumonia syndrome (IPS) versus graft-versus-host disease following allogeneic murine bone marrow transplantation. Biol Blood Marrow Transplant 2001, 7:368-377.
57. Shankar G, Cohen DA: Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol 2001, 82:101-113.
58. Cooke KR, Gerbitz A, Crawford JM, et al.: LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001, 107:1581-1589.
59. Schmaltz C, Alpdogan O, Horndasch KJ, et al.: Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 2001, 97:2886-2895.